In line with this, elevated IL-6 serum levels have been demonstrated as a predictor for the development of fatal pneumonia in patients with COVID-19, but are also associated with QT prolongation and persistent atrial inflammation, potentially leading to increased arrhythmia risk in COVID-19 (108, 111, 112). The gene discussed is IL6; the disease is COVID-19.